Published by Coherent Market Insights
Posted on September 14, 2021
4 min readLast updated: February 10, 2026
Add as preferred source on Google
Cytology refers to the microscopic examination of both plant and animal cell samples with regards to their structure, chemical composition, and function. The examination of cells can be carried out through various methods such as scraping the tissue surface, collection of bodily fluids, fine needle aspiration, and others. Histology refers to the microscopic study of the structure, chemical composition and function of animal and plant tissues. Histology requires a complicated slide preparation process, which usually include five steps i.e. fixation, processing, embedding, sectioning, and staining.
Staining helps in highlighting and enhancing the contrast of biological structures such as muscle fibers, a particular cell organelle or a blood cell type to be studied inside the bulk tissues. Many modernized staining techniques have been adopted in the field of histology and cytology to effectively study complex biological structures inside targeted cell or tissue. Some of these staining techniques include in-situ hybridization (ISH) and immunohistochemical (IHC) staining. Both histology and cytology are essential for diagnosis of diseases such as cervical cancer, oral cancer, smallpox, rabies, and others.
Request Sample Copy + related graphs of the report@ https://www.coherentmarketinsights.com/insight/request-sample/4591
The increasing incidence of cancer, rising research and development activities for the development of novel diagnostics for cancer, growing adoption of automation in histology and cytology are expected to drive growth of the global histology and cytology market. Moreover, increasing adoption of inorganic growth strategies such as partnerships, acquisitions, mergers and collaborations by key players operating in the market, are the major factors that are expected to drive growth of the global histology and cytology market over the forecast period.
For instance, according to the statistics provided by the National Institute of Cancer (NIC), U.S., in 2020 the rate of incidence of cancer was estimated to be 442.4 per 100,000 people, while the rate of deaths caused by cancer is estimated to be 158.3 per 100,000 people in the U.S. each year.
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 193,657,725 cases and 4,154,660 deaths due to coronavirus disease (COVID-19) were reported till July 25, 2021, across the globe.
Detailed Segmentation:
By Product Type:
By Examination Type:
By Test Type:
By End User:
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4591
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. However, COVID-19 pandemic is expected to have a positive impact on histology and cytology market in this COVID-19 pandemic, owing to partnerships between market players to develop novel methods for histological studies in COVID-19 infection, in order to understand the nature of the disease and assess its severity.
For instance, in September 2020, HistoWiz, Inc., a U.S.-based biotechnology company entered into a partnership with GeneTex, Inc., a U.S.-based biotechnology company to establish a number of validated antibodies for application in immunohistochemistry using human COVID-19 infected tissue sample.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Histology and Cytology Market Continues to Expand as Growing Adoption of Automation Technology appeared first on Gatorledger.
Cytology refers to the microscopic examination of both plant and animal cell samples regarding their structure, chemical composition, and function.
The growth is driven by the increasing incidence of cancer, rising research and development activities for novel diagnostics, and the growing adoption of automation in histology and cytology.
The COVID-19 pandemic has negatively affected the financial status of businesses across all sectors, including histology and cytology, due to lockdowns and disruptions in supply chains.
In September 2020, HistoWiz, Inc. partnered with GeneTex, Inc. to establish validated protocols for histology and cytology, highlighting the collaboration in the biotechnology field.
According to the National Institute of Cancer, the rate of cancer incidence in the US was estimated to be 442.4 per 100,000 people in 2020.
Explore more articles in the Research Reports category
